Latest Tarsons Products stock price

Tarsons Products P/E Ratio

TARSONS • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
59.48
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 59.48
Current Price ₹224.40
EPS (TTM) ₹5.60
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 69.12
Historical Range 44.24 - 94.01
Percentile 50.0%

Sector Context

Sector Average 57.3
Sector Median 35.38
Sector Rank #11 of 88
Sector Percentile 12.5%

Earnings Breakdown (TTM)

TTM EPS ₹4.81
Sept 2025 ₹0.62
Mar 2025 ₹1.92

Key P/E Ratio Insights for Tarsons Products

  • Stock appears overvalued with PE of 59.48, suggesting caution for new investments

View the TARSONS equity price for detailed stock performance.

P/E Ratio Historical Trend for Tarsons Products

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 94.01 5.61 ₹527.40 NSE High
2021 44.24 18.5 ₹818.40 NSE High

Sector P/E Ratio Comparison

Comparing Tarsons Products with other companies in Healthcare sector
Sector Average
57.3
Sector Median
35.38
Lowest P/E
9.01
Highest P/E
515.32
Companies
88
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low
Lincoln Pharmaceuticals LINCOLN 12.02 ₹974 Low
QMS Medical Allied Servi… QMSMEDI 12.82 ₹177 Low
Take Solutions TAKE 13.15 ₹638 Low
Venus Remedies VENUSREM 14.27 ₹995 Low
Royal Sense ROYAL 14.5 ₹96 Low
Bliss GVS Pharma BLISSGVS 16.62 ₹1,973 Moderate
RPG Life Sciences RPGLIFE 17.94 ₹3,861 Moderate